These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 4365523

  • 1. In vitro effects of synthetic somatotropin-release inhibiting factor on cyclic AMP level and GH release in rat anterior pituitary gland.
    Kaneko T, Oka H, Saito S, Munemura M, Musa K, Oda T.
    Endocrinol Jpn; 1973 Oct; 20(5):535-8. PubMed ID: 4365523
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of adenosine 3',5'-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormone.
    Borgeat P, Labrie F, Drouin J, Bélanger A, Immer H, Sestanj K, Nelson V, Götz M, Schally AV, Coy DH, Coy EJ.
    Biochem Biophys Res Commun; 1974 Feb 27; 56(4):1052-9. PubMed ID: 4363638
    [No Abstract] [Full Text] [Related]

  • 3. Somatostatin inhibition of rat growth hormone release in vitro in the presence of BaCl2 or 3-isobutyl-1-methylxanthine.
    Schofield JG, Mira-Moser F, Schorderet M, Orci L.
    FEBS Lett; 1974 Sep 15; 46(1):171-4. PubMed ID: 4371679
    [No Abstract] [Full Text] [Related]

  • 4. Effects of a purified growth hormone releasing factor on growth hormone secretion and pituitary cyclic nucleotide content.
    Peake GT, Wilson M, Steiner AL, Dhariwal AP.
    Metabolism; 1973 Jun 15; 22(6):769-72. PubMed ID: 4350846
    [No Abstract] [Full Text] [Related]

  • 5. Signal transduction systems employed by synthetic GH-releasing peptides in somatotrophs.
    Chen C, Wu D, Clarke IJ.
    J Endocrinol; 1996 Mar 15; 148(3):381-6. PubMed ID: 8778215
    [No Abstract] [Full Text] [Related]

  • 6. Effect of long-acting antagonists of growth hormone (GH)-releasing hormone on GH and cyclic adenosine 3',5'-monophosphate release in superfused rat pituitary cells.
    Horváth JE, Zarándi M, Groot K, Schally AV.
    Endocrinology; 1995 Sep 15; 136(9):3849-55. PubMed ID: 7649091
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of growth hormone and thyrotropin release by growth hormone-release inhibiting hormone.
    Belanger A, Labrie F, Borgeat P, Savary M, Cote J, Drouin J, Schally AV, Coy DH, Coy EJ, Sestanj K, Nelson V, Gotz M, Immer H.
    Mol Cell Endocrinol; 1974 Oct 15; 1(5):329-39. PubMed ID: 4375636
    [No Abstract] [Full Text] [Related]

  • 9. Characteristics of the desensitization of growth hormone and cyclic AMP responses to growth hormone-releasing factor and prostaglandin E2 in rat anterior pituitary cells in culture.
    Simard J, Labrie F.
    Mol Cell Endocrinol; 1986 Jun 15; 46(1):79-89. PubMed ID: 2423397
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Studies on growth hormone secretion. 3. Inhibition of prostaglandin, theophylline and cyclic amp stimulated growth hormone release by valinomycin in vitro.
    Hertelendy F, Peake G, Todd H.
    Biochem Biophys Res Commun; 1971 Jul 16; 44(2):253-60. PubMed ID: 4334132
    [No Abstract] [Full Text] [Related]

  • 14. Somatostatin prevents the desensitizing action of growth hormone-releasing factor on growth hormone release.
    Simard J, Lefèvre G, Labrie F.
    Peptides; 1987 Jul 16; 8(2):199-205. PubMed ID: 2884644
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.